Citation Impact
Citing Papers
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Personality Neuroscience and the Biology of Traits
2010
The effects of tryptophan depletion on mood and psychiatric symptoms
2001
Serotonin1A Receptors at the Axon Initial Segment of Prefrontal Pyramidal Neurons in Schizophrenia
2004
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Depression
2018 Standout
Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial
2005
International Consensus Study of Antipsychotic Dosing
2010
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Glutamate receptor ion channels
2005 Standout
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder
2011
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
The Serotonin-1A Receptor in Anxiety Disorders
2009
The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis
2007
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
2010
Neuroreceptor imaging in psychiatric disorders
2002
Adverse Health Effects of Marijuana Use
2014 Standout
Radioligand development for molecular imaging of the central nervous system with positron emission tomography
2014
How antipsychotics become anti-‘psychotic’ – from dopamine to salience to psychosis
2004
A broadly applicable [18F]trifluoromethylation of aryl and heteroaryl iodides for PET imaging
2013
Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice
2006
Descending control of pain
2002 Standout
Schizophrenia
2009 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Neuroimaging of child abuse: a critical review
2012 Standout
When brain clocks lose track of time: cause or consequence of neuropsychiatric disorders
2011 StandoutNobel
Fragments, network biology and designing multiple ligands
2006
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
2016
Polypharmacology of dopamine receptor ligands
2016
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
2008
Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder
2012
Converging evidence for abnormalities of the prefrontal cortex and evaluation of midsagittal structures in pediatric posttraumatic stress disorder: An MRI study
2009
Prefrontal neurons and the genetics of schizophrenia
2001
Effects of antipsychotics on brain structure
2006
Neural Correlates of Emotional Personality: A Structural and Functional Magnetic Resonance Imaging Study
2013
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
2011
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Two Randomized Placebo-Controlled Trials to Evaluate the Efficacy and Tolerability of Mirtazapine for the Treatment of Obstructive Sleep Apnea
2008
Modelling human drug abuse and addiction with dedicated small animal positron emission tomography
2008
Effects of Environmental Stress and Gender on Associations among Symptoms of Depression and the Serotonin Transporter Gene Linked Polymorphic Region (5-HTTLPR)
2007
Timing is everything: does the robust upregulation of noradrenergically regulated plasticity genes underlie the rapid antidepressant effects of sleep deprivation?
2002
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
2006
Foraging under Competition: The Neural Basis of Input-Matching in Humans
2013 StandoutNobel
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Insights into the ageing mind: a view from cognitive neuroscience
2004 Standout
In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders
2009
Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study
2002
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Occupancy of Serotonin Transporters by Paroxetine and Citalopram During Treatment of Depression: A [11C]DASB PET Imaging Study
2001
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease
2005
Parkinson's disease
2015 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
2005 StandoutNature
Brain correlates of music-evoked emotions
2014 Standout
Phospholipase C β4 in the Medial Septum Controls Cholinergic Theta Oscillations and Anxiety Behaviors
2009
Dose Response and Dose Equivalence of Antipsychotics
2004
Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis
2001
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
2009
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
Beyond diathesis stress: Differential susceptibility to environmental influences.
2009 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Reduced communication between frontal and temporal lobes during talking in schizophrenia
2002
Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study
2009
Major Depressive Disorder
2008 Standout
The neural basis of psychedelic action
2022 Standout
Sexual dysfunction and antipsychotic treatment
2002
Non-motor features of Parkinson disease
2017 Standout
Review article: intestinal serotonin signalling in irritable bowel syndrome
2006
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
Tachykinin receptor antagonists in clinical trials
2009
Sleep deprivation in depression
2010
fMRI of Cocaine Self-Administration in Macaques Reveals Functional Inhibition of Basal Ganglia
2011
Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders
2002
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Development of pharmacotherapies for drug addiction: a Rosetta Stone approach
2009
Socio-economic status covaries with central nervous system serotonergic responsivity as a function of allelic variation in the serotonin transporter gene-linked polymorphic region
2003
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Imagine All the People: How the Brain Creates and Uses Personality Models to Predict Behavior
2013 StandoutNobel
Neurocircuitry of Addiction
2009 Standout
The integration of negative affect, pain and cognitive control in the cingulate cortex
2011 Standout
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Elevated Central Serotonin Transporter Binding Availability in Acutely Abstinent Cocaine-Dependent Patients
2000
Clinical and Theoretical Implications of 5-HT2 and D2 Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in Schizophrenia
1999
Physiological Dysfunction of the Dorsolateral Prefrontal Cortex in Schizophrenia Revisited
2000
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4
2013 StandoutNobel
Neurobiology of alcohol dependence: focus on motivational mechanisms.
2008
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Cortical inhibitory neurons and schizophrenia
2005 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Therapeutic use of sleep deprivation in depression
2002
Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review
2007
Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts
2014
How antipsychotics work—From receptors to reality
2006
Differential aging of the human striatum: longitudinal evidence.
2003
NK1(TACR1) receptor gene ‘knockout’ mouse phenotype predicts genetic association with ADHD
2009
A systematic review of atypical antipsychotic drugs in schizophrenia
2003
Emerging drugs for schizophrenia
2008
Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds
2012
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
2007
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of J. Tauscher being referenced
Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism
2008 Science
Therapy of Treatment Resistant Depression: Focus on the Management of TRD with Atypical Antipsychotics
2004
A Risk-Benefit Assessment of Mirtazapine in the Treatment of Depression
1997
Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients
1998
Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression
1998
A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia
2000
Brain Serotonin 5-HT1A Receptor Binding in Schizophrenia Measured by Positron Emission Tomography and [11C]WAY-100635
2002
Volumetric MRI measurement of caudate nuclei in antipsychotic-naïve patients suffering from a first episode of psychosis
2004
Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia
1999
Equivalent Occupancy of Dopamine D1 and D2 Receptors With Clozapine: Differentiation From Other Atypical Antipsychotics
2004
In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol
1999
Inverse Relationship Between Serotonin 5-HT1A Receptor Binding and Anxiety: A [11C]WAY-100635 PET Investigation in Healthy Volunteers
2001
Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone
1996
Significant dissociation of brain and plasma kinetics with antipsychotics
2002
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2
2006
[123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder
2000
Imaging and Quantitation of Cannabinoid CB1 Receptors in Human and Monkey Brains Using 18F-Labeled Inverse Agonist Radioligands
2009
The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain
2007
Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder
2003
Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance
2000
Choosing the Right Dose of Antipsychotics in Schizophrenia
2001
Quetiapine: An Effective Antipsychotic in First-Episode Schizophrenia Despite Only Transiently High Dopamine-2 Receptor Blockade
2002
Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder
2006
The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development
2008
Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study
2002
Effects of Tryptophan Depletion in Drug-Free Depressed Patients Who Responded to Total Sleep Deprivation
1998
Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand
2009
11C-LY2428703, a positron emission tomographic radioligand for the metabotropic glutamate receptor 1, is unsuitable for imaging in monkey and human brains
2013
Dopamine depletion results in increased neostriatal D2, but not D1, receptor binding in humans
2002
No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism
2001
IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol
1997
A new algorithm for treating schizophrenia.
1998
Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
2000